Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02929056 · ClinicalTrials.gov registry record · Phase 4
Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations
A Phase 4 study, sponsored by Prisma Health-Upstate.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT02929056: Clinical Trial Phase 4 study, sponsored by Prisma Health-Upstate.
NCT02929056 is a Phase 4 study that was terminated before completion, run by Prisma Health-Upstate. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02929056, a Phase 4 study, was terminated before completion, sponsored by Prisma Health-Upstate.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate and compare healing characteristics, reduction in the size of the wound and to measure complete healing of the wound following the application of a biologic product dressing instead of the alginate dressing along with standard debridement and compression therapy versus the standard of care treatment for VLUs. The biologic product that will be used in this study is called AmnioExCel™.
Primary Outcome
Average percent change in wound area, computed with respect to wound area at time "0". Wound area assessed at baseline (time 0) and then weekly; change from baseline to 12 weeks reported.
Interventions
- BIOLOGICAL AmnioExCel dressing and compression therapy
- PROCEDURE SOC alginate dressing and compression therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2019-10-29 |
| Phase | Phase 4 |
Why NCT02929056 stopped before completion
NCT02929056 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which AmnioExCel dressing and compression therapy is the first listed.
NCT02929056 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02929056 about?
NCT02929056 is a clinical study titled "Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations". The purpose of this study is to evaluate and compare healing characteristics, reduction in the size of the wound and to measure complete healing of the wound following the application of a biologic product dressing instead of the alginate dressing along with standard debridement and compression ther...
What is the current status of trial NCT02929056?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2017-02-15. Estimated completion is 2019-10-29.
What interventions are being tested in trial NCT02929056?
The interventions under investigation include: AmnioExCel dressing and compression therapy (BIOLOGICAL), SOC alginate dressing and compression therapy (PROCEDURE).
Who is sponsoring clinical trial NCT02929056?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02929056's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI